Background The reported prevalence of cognitive impairment (CI) varies widely in cohorts of people living with HIV (PLWH); this may partly be due to the use of different diagnostic criteria. Agreement between diagnostic criteria of CI, the optimal definition to use, and associations with patient-reported cognitive symptoms have not been fully investigated. Methods Two hundred ninety PLWH aged >50 years and 97 matched negative controls completed a detailed assessment of cognitive function and three questions regarding cognitive symptoms. Age- and education-adjusted test scores (T-scores) determined if subjects met the following definitions of CI: Frascati, global deficit score (GDS) and the multivariate normative comparison (MNC) method. Res...
Background: HAART has contributed to decrease the HIV-related mortality and morbidity. However, the ...
Neurocognitive impairment (NCI) is common in people aging with HIV and can adversely affect health-r...
Because HIV-related neurocognitive impairment is usually mild and variable, clinical ratings (CR) an...
Background The reported prevalence of cognitive impairment (CI) varies widely in cohorts of people ...
Objectives: While cognitive impairment is frequently reported in HIV-positive individuals and has hi...
As the HIV population ages, the prevalence of cognitive impairment (CI) is increasing, yet few servi...
Background. The optimum method of defining cognitive impairment in virally suppressed people living ...
Background. The optimum method of defining cognitive impairment in virally suppressed people living ...
Background Combination antiretroviral therapy has dramatically improved the outlook for people livi...
Antiretroviral therapy has revolutionised the treatment for people living with HIV (PLWH). Where ant...
Although cognitive impairments are still prevalent in the current antiretroviral therapy era, limite...
Diagnosing neurocognitive impairment (NCI) in HIV infection requires time-consuming neuropsychologic...
<div><p>Objective</p><p>The reported prevalence of cognitive impairment remains similar to that repo...
To compare two definitions of neurocognitive impairment (NCI) in a large clinical trial of effective...
Background: HAART has contributed to decrease the HIV-related mortality and morbidity. However, the ...
Neurocognitive impairment (NCI) is common in people aging with HIV and can adversely affect health-r...
Because HIV-related neurocognitive impairment is usually mild and variable, clinical ratings (CR) an...
Background The reported prevalence of cognitive impairment (CI) varies widely in cohorts of people ...
Objectives: While cognitive impairment is frequently reported in HIV-positive individuals and has hi...
As the HIV population ages, the prevalence of cognitive impairment (CI) is increasing, yet few servi...
Background. The optimum method of defining cognitive impairment in virally suppressed people living ...
Background. The optimum method of defining cognitive impairment in virally suppressed people living ...
Background Combination antiretroviral therapy has dramatically improved the outlook for people livi...
Antiretroviral therapy has revolutionised the treatment for people living with HIV (PLWH). Where ant...
Although cognitive impairments are still prevalent in the current antiretroviral therapy era, limite...
Diagnosing neurocognitive impairment (NCI) in HIV infection requires time-consuming neuropsychologic...
<div><p>Objective</p><p>The reported prevalence of cognitive impairment remains similar to that repo...
To compare two definitions of neurocognitive impairment (NCI) in a large clinical trial of effective...
Background: HAART has contributed to decrease the HIV-related mortality and morbidity. However, the ...
Neurocognitive impairment (NCI) is common in people aging with HIV and can adversely affect health-r...
Because HIV-related neurocognitive impairment is usually mild and variable, clinical ratings (CR) an...